You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Vasculitis

Upadacitinib for treating giant cell arteritis [ID6299]

  • In development
  • Reference number: GID-TA11330
  • Expected publication date: TBC
  • Project information
  • Project documents

On this page

  1. Draft guidance
  2. Declaration of interests
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6299

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (downloadable version) (PDF 242 KB)

    Published:
    14 January 2026
  • Draft guidance (online commenting)

  • Committee papers (PDF 10.96 MB)

    Published:
    14 January 2026
  • Public committee slides (PDF 1.22 MB)

    Published:
    14 January 2026
  • Equality impact assessment (downloadable version) (PDF 129 KB)

    Published:
    14 January 2026

Declaration of interests

  • Register of interests (PDF 151 KB)

    Published:
    14 January 2026

Invitation to participate

  • Final scope (PDF 91 KB)

    Published:
    17 March 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 352 KB)

    Published:
    17 March 2025
  • Equality impact assessment (scoping) (PDF 51 KB)

    Published:
    17 March 2025
  • Final stakeholder list (PDF 93 KB)

    Published:
    23 May 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6299

  • Draft scope post referral (PDF 166 KB)

    Published:
    23 January 2025
  • Draft matrix post referral (PDF 164 KB)

    Published:
    23 January 2025
Back to top